Skip to main content

Drugging the Disorderome

Strategies for targeting intrinsically disordered proteins

Written byAmber Dance
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00

PROMISING PAIRS: An NMR screen for inhibitors of the cell cycle regulator p27Kip1 yielded a number of hits, which clustered into two groups that bind to different parts of the protein. Here are representative small molecules that bind to the two different regions. The colors of the polygons reflect the binding site characteristics favored by inhibitors (blue, electropositive; red, electronegative; gold, hydrophobic; yellow, van der Waal) and the polygons’ sizes indicate the favorability of the contact interaction.SCI REP, 5:15686, 2015

Scientists know a lot about drugs for proteins that settle down into nice, stable conformations and stick with them. Not so for the set known as intrinsically disordered proteins, or IDPs. Their amino acid chains rapidly cycle between multiple conformations, sometimes within microseconds. They’re continually striking different poses, like a nanoscopic, superspeed version of Madonna in her music video “Vogue.”

As many as one-third to one-half of human proteins are partially or fully disordered, and those proteins are common in signaling and disease pathways. Normally tightly regulated, IDPs are multitasking molecules that can be swiftly repurposed and reconfigured to play roles in multiple regulatory cascades. But when their expression is altered, IDPs can be implicated in conditions such as cancer, cardiovascular disease, and neurodegeneration. Their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Amber Dance is an award-winning freelance science journalist based in Southern California. After earning a doctorate in biology, she re-trained in journalism as a way to engage her broad interest in science and share her enthusiasm with readers. She mainly writes about life sciences, but enjoys getting out of her comfort zone on occasion.

    View Full Profile

Related Topics

Published In

October 2017

A Natural Archive

The practical challenges of storing data in DNA

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo